NanoString Technologies Prices Initial Public Offering
June 25, 2013
SEATTLE, Wash. – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its initial public offering of 5.4 million shares of common stock at a price to the public of $10.00 per share. In addition, the Company has granted the underwriters a 30-day [...]
3D Spheroid Assays for Cancer Drug Screening
June 25, 2013
AMSBIO has introduced a new range of 96-well format 3D Spheroid Cell Proliferation / Viability Assays, providing a new tool to allow cell-based assays to be carried out in 3D. The new AMSBIO 3D Spheroid Proliferation/Viability Assay provides a useful tool for modeling tumor response in vitro. The kit utilises a 3D Culture Qualified 96 [...]
BioLife Solutions Announces Strategic Partnership with HemaCare
June 25, 2013
BOTHELL, Wash., -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic [...]
June 25, 2013
Salisbury, UK,: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being implemented for the further characterization of natural colloids (inorganic and organic) at the Institute of Water Resources and Water Supply at the Technical University Hamburg-Harburg in Germany. Inorganic and organic colloids are widespread in aquatic systems, where they influence many water quality treatment [...]
June 25, 2013
LANCASTER, Calif.-- Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a Material Transfer Agreement (MTA) with the Division of the National Toxicology Program (DNTP) of the U.S. National Institute of Environmental Health Sciences (NIEHS) to provide licenses for its GastroPlus™, [...]
BioFire Receives FDA Clearance for the FilmArray® Blood Culture Identification Panel
June 25, 2013
SALT LAKE CITY - BioFire Diagnostics, Inc., announced today the FDA clearance of its FilmArray Blood Culture Identification (BCID) Panel. To date, the 27-target panel is the most comprehensive test to be approved by the FDA. The FilmArray BCID Panel provides results from positive blood cultures, and can identify more than 100 blood pathogens known [...]
Miltenyi Biotec receives manufacturing license for therapeutic antibody MB101
June 25, 2013
TETEROW, GERMANY, — Miltenyi Biotec GmbH today announced that the German medical regulatory authorities, the Arzneimittelüberwachungsbehörde (AMÜSt) of Mecklenburg-Vorpommern and the Paul-Ehrlich-Institut (PEI), have granted a license for the manufacture of the clinical lead candidate, MB101, at its GMP facility in Teterow, Germany. MB101 is a proprietary humanized, monoclonal antibody directed against an undisclosed target [...]
June 25, 2013
IRVINE, Calif.,-- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its chromosomal microarray analysis (CMA) test for miscarriage analysis has received conditional approval from the New York State's Department of Health for testing on patient samples from the state. With nearly 20 million [...]
Kewaunee Scientific Reports Record Sales for Year and Fourth Quarter
June 25, 2013
STATESVILLE, N.C. -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and year ended April 30, 2013. Fiscal Year 2013 Results Sales for the year were a record $117,121,000, up 13.9% from sales of $102,847,000 in the prior year. Net earnings for the year were $3,044,000, or $1.17 per diluted share, [...]
June 25, 2013
SAN JOSE, Calif. – Thermo Fisher Scientific Inc., the world leader in serving science, and the Newman-Lakka Institute for Personalized Cancer Care at Floating Hospital for Children at Tufts Medical Center, announced an intended collaboration for research and development of new methods to detect and track circulating biomarkers in blood. The collaboration will focus on [...]

